Raporty Spółek ESPI/EBI

Publication of materials for holding an Extraordinary General Meeting of Shareholders of "Sopharma" AD, scheduled for 15 January 2027 SOPHARMA AD (BG11SOSOBT18)

18-11-2026 16:40:11 | ESPI | 303/2026
oUNI-EN: Publication of materials for holding an Extraordinary General Meeting of Shareholders of "Sopharma" AD, scheduled for 15 January 2027

PAP
Data: 2026-11-18

Firma: SOPHARMA AD

oSpis tresci:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

oSpis zalacznikow:
Znaleziono 1 załącznik
  • SFA_EGM_15012027_EN.zip
  • Arkusz: REPORT

    Nazwa arkusza: REPORT


    POLISH FINANCIAL SUPERVISION AUTHORITY
    UNI - EN REPORT No 303 / 2026
    Date of issue: 2026-11-18
    Short name of the issuer
    SOPHARMA AD
    Subject
    Publication of materials for holding an Extraordinary General Meeting of Shareholders of "Sopharma" AD, scheduled for 15 January 2027
    Official market - legal basis
    Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe
    Unofficial market - legal basis
    Contents of the report:
    Sofia, Bulgaria, November 18, 2026 - According to the requirements of Art. 100t of the Law on Public Offering of Securities the Board of directors of "Sopharma" AD _SFA: "BSE" AD, SPH: Warsaw Stock Exchange_ presents the following materials on the agenda of EGM convened for January 15, 2027 and in the absence of a quorum on this date - for February 05, 2027, to the attention of shareholders, which will be available on the website of Extri News _www.x3news.com_, in the FSC system, on the Company's website www.sopharmagroup.com and on the website www.investor.bg, as well as in hard copy at the address of the Company:
    Annexes
    File Description
    SFA_EGM_15012027_EN.zip Publication of materials for holding an Extraordinary General Meeting of Shareholders of "Sopharma" AD, scheduled for 15 January 2027

    Nazwa arkusza: ESAP METADATE


    Legal framework Type of information
    TRANSD Inside information
    RegulatoryData
    Collection Body PLKNF
    Unique data record identifier
    Type of submission New _to be used for new information_
    Voluntary information flag
    Date or period covered [Date or beginning of the period to which the information relates] 2027-01-15
    Date or period covered [Date or end of the period to which the information relates] 2027-01-15
    Personal data flag
    Macierzyste państwo członkowskie, w stosownych przypadkach PL
    DocumentReference
    Język, w którym przekazano informacje Oryginał _ORIG_ czy tłumaczenie _TRAN_ Numer referencyjny pliku danych
    PL ORIG
    SubmittingEntity
    Submitting entity LEI or Submitting entity name - natural person
    RelatedEntity/LegalPerson
    Entity LEI Size of the entity Industry sector_s_
    097900BGGW0000048796 Large undertaking _acc. NACE_: C

    Nazwa arkusza: INFORMATION ABOUT THE ENTITY


    SOPHARMA AD
    _fullname of the issuer_
    SOPHARMA AD Farmaceutyczny _far_
    _short name of the issuer_ _sector according to clasification
    of the WSE in Warsow_
    1220 Sofia
    _post code_ _city_
    IlienskoShosse 16
    _street_ _number_
    +359 2 813 42 00 +359 2 936 02 86
    _phone number_ _fax_
    _e-mail_ _web site_
    nd
    _NIP_ _REGON_

    Nazwa arkusza: SIGNATURE OF PERSONS REPRESENTING THE COMPANY


    SIGNATURE OF PERSONS REPRESENTING THE COMPANY
    Date Name Position / Function Signature
    2026-11-18 Ognian Ivanov Donev Executive Director


    Identyfikator raportu jjvuszwyf1
    Nazwa raportu UNI-EN
    Symbol raportu UNI-EN
    Nazwa emitenta SOPHARMA AD
    Symbol Emitenta SOPHARMA AD
    Tytul Publication of materials for holding an Extraordinary General Meeting of Shareholders of "Sopharma" AD, scheduled for 15 January 2027
    Sektor Farmaceutyczny (far)
    Kod 1220
    Miasto Sofia
    Ulica IlienskoShosse
    Nr 16
    Tel. +359 2 813 42 00
    Fax +359 2 936 02 86
    e-mail
    NIP nd
    REGON
    Data sporzadzenia 2026-11-18
    Rok biezacy 2026
    Numer 303
    adres www
    Serwis Ekonomiczny Polskiej Agencji Prasowej SA 2026 Copyright PAP SA - Wszelkie prawa zastrzezone.